BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9671313)

  • 1. Blockade of TGFbeta3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells.
    Yue J; Buard A; Mulder KM
    Oncogene; 1998 Jul; 17(1):47-55. PubMed ID: 9671313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta.
    Yue J; Frey RS; Mulder KM
    Oncogene; 1999 Mar; 18(11):2033-7. PubMed ID: 10208426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered transforming growth factor signaling in epithelial cells when ras activation is blocked.
    Hartsough MT; Frey RS; Zipfel PA; Buard A; Cook SJ; McCormick F; Mulder KM
    J Biol Chem; 1996 Sep; 271(37):22368-75. PubMed ID: 8798398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Herr KD; Wenner CE
    Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.
    Mal A; Poon RY; Howe PH; Toyoshima H; Hunter T; Harter ML
    Nature; 1996 Mar; 380(6571):262-5. PubMed ID: 8637577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
    Crowe DL; Shuler CF
    Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation.
    Zhou P; Yao Y; Soh JW; Weinstein IB
    Anticancer Res; 1999; 19(6B):4935-45. PubMed ID: 10697493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F; Taipale M; Heiskanen A; Laiho M
    Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclin E overexpression on cell growth and response to transforming growth factor beta depend on cell context and p27Kip1 expression.
    Sgambato A; Doki Y; Schieren I; Weinstein IB
    Cell Growth Differ; 1997 Apr; 8(4):393-405. PubMed ID: 9101085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
    Wu G; Fan RS; Li W; Ko TC; Brattain MG
    Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
    Goubin F; Ducommun B
    Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cell adhesion to substratum up-regulates p21Cip1/WAF1 expression in BALB/c 3T3 fibroblasts.
    Kuzumaki T; Ishikawa K
    Biochem Biophys Res Commun; 1997 Sep; 238(1):169-72. PubMed ID: 9299473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
    Klausen P; Pedersen L; Jurlander J; Baumann H
    Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.
    Levkau B; Koyama H; Raines EW; Clurman BE; Herren B; Orth K; Roberts JM; Ross R
    Mol Cell; 1998 Mar; 1(4):553-63. PubMed ID: 9660939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
    Yan Z; Kim GY; Deng X; Friedman E
    J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
    Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.
    Peng D; Fan Z; Lu Y; DeBlasio T; Scher H; Mendelsohn J
    Cancer Res; 1996 Aug; 56(16):3666-9. PubMed ID: 8706005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.